Implantable defibrillator-detected heart failure status predicts atrial fibrillation occurrence.
暂无分享,去创建一个
M. Bertini | A. Dello Russo | C. Lavalle | L. Calò | A. Rapacciuolo | S. Valsecchi | L. Santini | D. Pecora | V. Tavoletta | R. Calvanese | V. E. Santobuono | G. Savarese | M. Campari | C. Amellone | F. Vitali | Angelo Giano | Agostino Mattera | A. Mattera | A. Giano | V. Santobuono
[1] L. Allen,et al. Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF) - Phase I Evaluation of the Integration and Safety of the HeartLogic Multisensor Algorithm in Patients With Heart Failure. , 2022, Journal of cardiac failure.
[2] M. Ziacchi,et al. Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management , 2021, Circulation. Heart failure.
[3] A. Capucci,et al. Prospective evaluation of the multisensor HeartLogic algorithm for heart failure monitoring , 2020, Clinical cardiology.
[4] A. Capucci,et al. ICD-measured heart sounds and their correlation with echocardiographic indexes of systolic and diastolic function , 2020, Journal of Interventional Cardiac Electrophysiology.
[5] J. P. Piccini,et al. Heart Failure and Atrial Fibrillation, Like Fire and Fury. , 2019, JACC. Heart failure.
[6] A. Farcomeni,et al. Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices , 2019, Clinical Research in Cardiology.
[7] Michael Cao,et al. HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results From the MultiSENSE Study , 2018, Circulation. Heart failure.
[8] A. Capucci,et al. Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure. , 2018, Journal of the American College of Cardiology.
[9] D. Packer,et al. Evaluation of shortness of breath after atrial fibrillation ablation-Is there a stiff left atrium? , 2018, Heart rhythm.
[10] R. Tieleman,et al. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE) , 2018 .
[11] Rajiv Mahajan,et al. Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis , 2018, European heart journal.
[12] L. Jordaens,et al. Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.
[13] Giuseppe Boriani,et al. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden. , 2017, Heart rhythm.
[14] Akshay S. Desai,et al. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction. , 2017, Journal of the American College of Cardiology.
[15] A. Capucci,et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT , 2017, European heart journal.
[16] Yi Zhang,et al. A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study. , 2017, JACC. Heart failure.
[17] G. Lip,et al. Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease. , 2016, Journal of the American College of Cardiology.
[18] R. Hunter,et al. Comorbidity of atrial fibrillation and heart failure , 2016, Nature Reviews Cardiology.
[19] Renato Pietro Ricci,et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. , 2015, Heart rhythm.
[20] A. Rigby,et al. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFÉ-II Study) , 2009, Heart.
[21] Nick Freemantle,et al. Effect of Cardiac Resynchronization on the Incidence of Atrial Fibrillation in Patients With Severe Heart Failure , 2006, Circulation.
[22] A. Moss,et al. Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. , 2006, Heart rhythm.
[23] C. Lau,et al. Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization , 2005, Circulation.
[24] Karl Swedberg,et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. , 2005, European heart journal.
[25] J. Murabito,et al. Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.
[26] D. Levy,et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.